In our study, Ang II triggered the inflammatory injury, enhanced transcytosis and eNOS/iNOS imbalance-induced endothelial dysfunction in ECs through activating the TLR4 signalling pathway and then led to BBB disruption. The gene discussed is AGT; the disease is endothelial dysfunction.